RNAM
Avidity Biosciences
RNAM
RNAM
Delisted
RNAM was delisted on the 26th of February, 2026.
245 hedge funds and large institutions have $5.8B invested in Avidity Biosciences in 2024 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 86 increasing their positions, 62 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
25% more funds holding
Funds holding: 196 → 245 (+49)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
9.22% less ownership
Funds ownership: 117.09% → 107.87% (-9.2%)
Holders
245
Holding in Top 10
10
Calls
$10.7M
Puts
$7.5M
Top Buyers
| 1 | +$142M | |
| 2 | +$140M | |
| 3 | +$60.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$53.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$50M |
Top Sellers
| 1 | -$210M | |
| 2 | -$29.2M | |
| 3 | -$27.9M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$26.8M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$24.9M |